Literature DB >> 24559186

Increased risk of cancer for patients with ankylosing spondylitis: a nationwide population-based retrospective cohort study.

L-M Sun1, C-H Muo, J-A Liang, S-N Chang, F-C Sung, C-H Kao.   

Abstract

OBJECTIVES: Few studies have investigated the relationship between ankylosing spondylitis (AS) and other inflammatory spondyloarthritis and subsequent cancer. The aim of this study was to determine whether AS is associated with cancer risk.
METHOD: We used data from the National Health Insurance (NHI) system of Taiwan to investigate this association. The AS cohort included 4133 patients, and each patient was randomly frequency matched with four persons without AS based on sex, age, and entry year (control cohort). We conducted a Cox proportional hazards regression analysis to estimate the influence of AS on cancer risk.
RESULTS: Among patients with AS, the overall risk of developing cancer was 38% higher than that of people without AS, and the difference was significant [adjusted hazard ratio (HR) 1.38, 95% confidence interval (CI) 1.18-1.60]. This phenomenon held true even when we analysed males and females separately. The risk of developing lung or head and neck cancer among patients with AS was significantly higher; and risks for liver, bladder, and uterus cancers were marginally significantly higher.
CONCLUSIONS: This nationwide population-based cohort study shows that Taiwanese patients with AS have a higher risk of developing cancer, particularly lung or head and neck cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24559186     DOI: 10.3109/03009742.2013.863969

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  11 in total

1.  Ankylosing spondylitis and the risk of cancer.

Authors:  Chih-Cheng Chang; Cheng-Wei Chang; Phung-Anh Alex Nguyen; Tzu-Hao Chang; Ya-Ling Shih; Wen-Ying Chang; Jorng-Tzong Horng; Oscar Kuang-Sheng Lee; Jennifer Hui-Chun Ho
Journal:  Oncol Lett       Date:  2017-06-09       Impact factor: 2.967

2.  Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database.

Authors:  Mohamad Bittar; Sali Merjanah; Reem Alkilany; Marina Magrey
Journal:  BMC Rheumatol       Date:  2022-06-30

3.  All-Cause and Cause-Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta-Analysis.

Authors:  Haseeb Chaudhary; Nidrit Bohra; Khezar Syed; Anthony Donato; M Hassan Murad; Paras Karmacharya
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-11-17       Impact factor: 5.178

4.  The risk of asthma in patients with ankylosing spondylitis: a population-based cohort study.

Authors:  Te-Chun Shen; Cheng-Li Lin; Chang-Ching Wei; Chia-Hung Chen; Chih-Yen Tu; Te-Chun Hsia; Chuen-Ming Shih; Wu-Huei Hsu; Fung-Chang Sung
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 5.  Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis.

Authors:  Chuiwen Deng; Wenli Li; Yunyun Fei; Yongzhe Li; Fengchun Zhang
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

Review 6.  The Efficacy and Safety of Simple-Needling Therapy for Treating Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yichen Xuan; Hui Huang; Yiyong Huang; Duanyong Liu; Xiuwu Hu; Lele Geng
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-13       Impact factor: 2.629

7.  Evidence for an Association between Macular Degeneration and Thyroid Cancer in the Aged Population.

Authors:  Shih-Yi Lin; Wu-Huei Hsu; Cheng-Li Lin; Cheng-Chieh Lin; Jane-Ming Lin; Yun-Lun Chang; Chung-Y Hsu; Chia-Hung Kao
Journal:  Int J Environ Res Public Health       Date:  2018-05-03       Impact factor: 3.390

8.  Evaluation of the comorbidity burden in patients with ankylosing spondylitis treated with tumour necrosis factor inhibitors using a large administrative claims data set.

Authors:  Jessica A Walsh; Xue Song; Gilwan Kim; Yujin Park
Journal:  J Pharm Health Serv Res       Date:  2018-01-16

9.  Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry.

Authors:  Philip J Mease; Désirée van der Heijde; Chitra Karki; Mei Liu; Yujin Park; Jeffrey D Greenberg
Journal:  Rheumatol Ther       Date:  2018-10-23

10.  Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.

Authors:  Markéta Hušáková; Anne-C Bay-Jensen; Šárka Forejtová; Kateřina Zegzulková; Michal Tomčík; Monika Gregová; Kristýna Bubová; Jana Hořínková; Jindra Gatterová; Karel Pavelka; Anne Sofie Siebuhr
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.